Correlation Between Century Therapeutics and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Enliven Therapeutics, you can compare the effects of market volatilities on Century Therapeutics and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Enliven Therapeutics.
Diversification Opportunities for Century Therapeutics and Enliven Therapeutics
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Century and Enliven is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Century Therapeutics and Enliven Therapeutics
Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the Enliven Therapeutics. In addition to that, Century Therapeutics is 1.1 times more volatile than Enliven Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest 1,492 in Enliven Therapeutics on August 28, 2024 and sell it today you would earn a total of 996.00 from holding Enliven Therapeutics or generate 66.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Century Therapeutics vs. Enliven Therapeutics
Performance |
| Timeline |
| Century Therapeutics |
| Enliven Therapeutics |
Century Therapeutics and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Century Therapeutics and Enliven Therapeutics
The main advantage of trading using opposite Century Therapeutics and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Century Therapeutics vs. Eliem Therapeutics | Century Therapeutics vs. HCW Biologics | Century Therapeutics vs. Scpharmaceuticals | Century Therapeutics vs. Milestone Pharmaceuticals |
| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |